Document is current
Any future updates will be listed below
-
Authors
Zhang, Qing https://orcid.org/0000-0002-0203-4437
Lasanajak, Yi
Yan, Menxin
Chen, Golden
Song, Xuezheng https://orcid.org/0000-0003-1751-2785
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM137011, R44GM133252)
- License Information
-
More Information
Article History
Received: 14 December 2024
Accepted: 24 March 2025
First Online: 4 April 2025
Competing interests
: The authors declare the following competing financial interest(s): X.S. is co-founder and consultant of NatGlycan LLC, which is commercializing the ORNG technology. All other authors declare no competing interests.
